Mauch Jacqueline Y, Kutter Annette P N, Martin Jurado Olga, Madjdpour Caveh, Spielmann Nelly, Frotzler Angela, Bettschart-Wolfensberger Regula, Weiss Markus
Department of Anesthesia and Perioperative Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Paediatr Anaesth. 2011 Feb;21(2):136-40. doi: 10.1111/j.1460-9592.2010.03466.x. Epub 2010 Nov 28.
Intravascular application of a small dose of local anesthetics (LA) with epinephrine as well as larger doses of LA under sevoflurane anesthesia results in increase in T-wave amplitude in the electrocardiogram (ECG). The aim of this study was to elucidate whether propofol anesthesia affects these ECG alterations or not.
Thirty neonatal pigs were randomized into two groups. Group 1 was anesthetized with sevoflurane, group 2 with sevoflurane plus continuous propofol infusion (10 mg·kg(-1)·h(-1)). A test dose of 0.2 ml·kg(-1) bupivacaine 0.125% + epinephrine 1 : 200,000 was injected intravenously. Arterial pressure was monitored. ECG was analyzed for changes in T-wave amplitude (positive if ≥25% baseline) and heart rate. In another setting, bupivacaine 0.125% was intravenous infused at a rate of 4 mg·kg(-1)·min(-1). ECG was analyzed for alteration in T-wave amplitude and heart rate at 1.25, 2.5, and 5 mg·kg(-1) bupivacaine infused.
T-wave elevation after the administration of an epinephrine containing LA test dose was similar between the two groups. Increase in heart rate caused by the test dose were significantly higher in group 2 (P = 0.008). During continuous bupivacaine administration, T-wave elevation occurred in 40% and 71% (group 1 and 2) at 1.25 mg·kg(-1), in 80% and 100% at 2.5 mg·kg(-1), and in 93% and 86% at 5 mg·kg(-1) bupivacaine infused.
Continuous propofol infusion does not suppress the ECG signs of a systemically administered epinephrine containing LA test dose nor does it suppress the ECG signs caused by high doses of intravenous applied bupivacaine.
在七氟醚麻醉下,血管内应用小剂量含肾上腺素的局部麻醉药(LA)以及较大剂量的LA会导致心电图(ECG)中T波振幅增加。本研究的目的是阐明丙泊酚麻醉是否会影响这些心电图改变。
30只新生猪被随机分为两组。第1组用七氟醚麻醉,第2组用七氟醚加持续输注丙泊酚(10mg·kg⁻¹·h⁻¹)。静脉注射0.2ml·kg⁻¹ 0.125%布比卡因+1:200,000肾上腺素的试验剂量。监测动脉血压。分析心电图的T波振幅变化(若≥基线的25%为阳性)和心率。在另一种情况下,以4mg·kg⁻¹·min⁻¹的速率静脉输注0.125%布比卡因。在输注1.25、2.5和5mg·kg⁻¹布比卡因时分析心电图的T波振幅和心率变化。
两组在给予含肾上腺素的LA试验剂量后T波升高情况相似。试验剂量引起的心率增加在第2组显著更高(P = 0.008)。在持续输注布比卡因期间,在输注1.25mg·kg⁻¹时,第1组和第2组分别有40%和71%出现T波升高,在输注2.5mg·kg⁻¹时分别为80%和100%,在输注5mg·kg⁻¹布比卡因时分别为93%和86%。
持续输注丙泊酚既不抑制全身应用含肾上腺素的LA试验剂量后的心电图表现,也不抑制高剂量静脉应用布比卡因引起的心电图表现。